Inactivated Viral Transport Medium Kit & Non Inactivated Type Viral
Transport Medium For RT-PCR
Inactivated Viral Transport Medium Kit
The Viral Transport Medium is intended for the collection and
transport of clinical samples containing viruses, chlamydiae,
mycoplasmas and ureaplasmas from the collection site to the testing
laboratory.
Viral Transport Medium (Non-inactivated Type)
The Viral Transport Medium is intended for the collection and
transport of clinical samples containing viruses, chlamydiae,
mycoplasmas and ureaplasmas from the collection site to the testing
laboratory.
| Format: | Tube WithTransparent Reagent | Certificate: | CE, ISO13485 |
| Pack: | 1mL/T, 2mL/T, 3mL/T, 5mL/T, 50T/box | Storage Temperature: | 2 ~ 25℃ |
| Shelf Life: | 1 Year | FEATURES 1: | Directly Lyse The Virus And Release Nucleic Acid |
| FEATURES 2: | Suitable For RT-PCR | FEATURES 3: | Quickly Inactivate The Virus |
| FEATURES 4: | Eliminate The Risk Of Infection | | |
PRODUCT FEATURES - Inactivated Viral Transport Medium Kit
Directly lyse the virus and release nucleic acid
Suitable for RT-PCR
Quickly inactivate the virus
Eliminate the risk of infection
PRODUCT FEATURES - Viral Transport Medium (Non-inactivated Type)
Maintain the viability of the organisms
Maintain the originality of the organisms to the greatest extent
Anti-bacterial and anti-fungal
[Preservation]
Storage: 5-25℃ Expiration date: 12 months
Please refer to the outer box for the production date and
expiration date.
[Sample Requirements]
The collected nasopharyngeal swab samples should be transported at
2°C-8°C and submitted for inspection immediately. Sample transport
and storage time should be no later than 48h.
[Testing method]
1. Before sampling, mark the relevant sample information on the
label of the sampling tube.
2. Use a sampling swab to sample at the nasopharynx up to different
sampling requirements.
3. Sampling methods are below:
a. Nasal swab: Gently insert the swab head into the nasal condyle
of the nasal passage, stay for a while and then slowly turn it out.
Wipe the other nostril with another swab, immerse the swab head in
the sampling solution, and discard the tail.
b. Pharyngeal swab: Wipe the bilateral pharyngeal tonsils and
posterior pharyngeal wall with the swab, immerse the swab head in
the sampling solution, and discard the tail.
4. Quickly place the swab into the sampling tube.
5. Break the sampling swab above the sampling tube, and tighten the
tube cap.
6. Freshly collected clinical specimens should be delivered to the
laboratory within 2 hours at 2°C-8°C.
[Interpretation of results]
If the collected sampling solution turns yellow or turbid, the
sample should be re-sampled for testing.
[Method limitations]
1. Contaminated samples after collection will affect the final
results.
2. Store samples at inappropriate temperature will affect the final
results.
Advantages:
•Directly lyse the virus and release nucleic acid, suitable for
RT-PCR
•Quickly inactivate the virus, eliminate the risk of infection
